Biosimilar recombinant human erythropoietin induces the production of neutralizing antibodies
Biosimilar recombinant human erythropoietin induces the production of neutralizing antibodies
About this item
Full title
Author / Creator
Praditpornsilpa, Kearkiat , Tiranathanagul, Khajohn , Kupatawintu, Pawinee , Jootar, Saengsuree , Intragumtornchai, Tanin , Tungsanga, Kriang , Teerapornlertratt, Tanyarat , Lumlertkul, Dusit , Townamchai, Natavudh , Susantitaphong, Paweena , Katavetin, Pisut , Kanjanabuch, Talerngsak , Avihingsanon, Yingyos and Eiam-Ong, Somchai
Publisher
Basingstoke: Elsevier Inc
Journal title
Language
English
Formats
Publication information
Publisher
Basingstoke: Elsevier Inc
Subjects
More information
Scope and Contents
Contents
Recombinant human erythropoietin (r-HuEpo) has been used for the treatment of renal anemia. With the loss of its patent protection, there has been an upsurge of more affordable biosimilar agents, increasing patient access to treatment for these conditions. The complexity of the manufacturing process for these recombinant proteins, however, can resu...
Alternative Titles
Full title
Biosimilar recombinant human erythropoietin induces the production of neutralizing antibodies
Authors, Artists and Contributors
Author / Creator
Tiranathanagul, Khajohn
Kupatawintu, Pawinee
Jootar, Saengsuree
Intragumtornchai, Tanin
Tungsanga, Kriang
Teerapornlertratt, Tanyarat
Lumlertkul, Dusit
Townamchai, Natavudh
Susantitaphong, Paweena
Katavetin, Pisut
Kanjanabuch, Talerngsak
Avihingsanon, Yingyos
Eiam-Ong, Somchai
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_872126801
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_872126801
Other Identifiers
ISSN
0085-2538
E-ISSN
1523-1755
DOI
10.1038/ki.2011.68
